ATE421883T1 - Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline - Google Patents
Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobulineInfo
- Publication number
- ATE421883T1 ATE421883T1 AT99969030T AT99969030T ATE421883T1 AT E421883 T1 ATE421883 T1 AT E421883T1 AT 99969030 T AT99969030 T AT 99969030T AT 99969030 T AT99969030 T AT 99969030T AT E421883 T1 ATE421883 T1 AT E421883T1
- Authority
- AT
- Austria
- Prior art keywords
- glucan
- compositions containing
- specific immunoglobulins
- containing beta
- beta
- Prior art date
Links
- 229920002498 Beta-glucan Polymers 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229940043517 specific immunoglobulins Drugs 0.000 title abstract 2
- SPMCUTIDVYCGCK-IIIGWGBSSA-N (2s,3r,4s,5r,6r)-2-[(2r,3r,4r,5s)-3,5-dihydroxy-2-(hydroxymethyl)oxan-4-yl]oxy-4-[(2s,3r,5s,6r)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-3,5-diol Chemical compound O[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)OC[C@@H]2O)O)O[C@H](CO)[C@H]1O SPMCUTIDVYCGCK-IIIGWGBSSA-N 0.000 title 1
- 244000000010 microbial pathogen Species 0.000 abstract 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10014698P | 1998-09-14 | 1998-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421883T1 true ATE421883T1 (de) | 2009-02-15 |
Family
ID=22278313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99969030T ATE421883T1 (de) | 1998-09-14 | 1999-09-14 | Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6355625B1 (de) |
| EP (1) | EP1121135B1 (de) |
| AT (1) | ATE421883T1 (de) |
| AU (1) | AU6033299A (de) |
| CA (1) | CA2344166C (de) |
| CY (1) | CY1109437T1 (de) |
| DE (1) | DE69940371D1 (de) |
| DK (1) | DK1121135T3 (de) |
| ES (1) | ES2321892T3 (de) |
| PT (1) | PT1121135E (de) |
| WO (1) | WO2000015238A1 (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610293B1 (en) * | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| US6756361B1 (en) * | 1997-10-14 | 2004-06-29 | Nabi | Enterococcus antigens and vaccines |
| US7030101B2 (en) * | 1998-09-14 | 2006-04-18 | Nabi Biopharmaceuticals | Compositions of β-glucans and specific antibodies |
| US6936258B1 (en) * | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
| US7507724B2 (en) | 2001-01-16 | 2009-03-24 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
| WO2002058711A1 (en) | 2001-01-16 | 2002-08-01 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
| US7786094B2 (en) * | 2001-10-09 | 2010-08-31 | Biopolymer Engineering, Inc. | Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| EP1539194A4 (de) | 2002-09-04 | 2007-06-13 | Univ Louisville Res Found | Krebstherapie mit beta-glucan und antikörpern |
| US20060165700A1 (en) * | 2002-09-04 | 2006-07-27 | Ostroff Gary R | Cancer therapy using whole glucan particles and antibodies |
| US20090169557A1 (en) * | 2004-05-10 | 2009-07-02 | Biopolymer Engineering, Inc. D/B/A Biothera | Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies |
| JP2008513406A (ja) | 2004-09-22 | 2008-05-01 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| US20060134141A1 (en) * | 2004-12-14 | 2006-06-22 | Nabi Biopharmaceuticals | Glycoconjugate vaccines containing peptidoglycan |
| KR20070104590A (ko) * | 2005-01-10 | 2007-10-26 | 나비 바이오파마슈티컬즈 | 스타필로코쿠스 아우레우스 감염을 치료하는 방법 |
| US20060228368A1 (en) * | 2005-04-07 | 2006-10-12 | Nabi Biopharmaceuticals | Method of protecting against staphylococcal infection |
| EP1917019A2 (de) * | 2005-05-03 | 2008-05-07 | Biopolymer Engineering, Inc. | Kombination eines beta-glucans und eines egf-rezeptor-antagonisten zur krebs- und infektionsbehandlung |
| MX2007013725A (es) * | 2005-05-05 | 2008-04-09 | Sensient Flavors Inc | Produccion de beta-glucanos y mananos. |
| CN102698261A (zh) | 2005-06-13 | 2012-10-03 | 葛兰素史密斯克蓝生物品公司 | Panton-valentine杀白细胞素用于治疗和预防葡萄球菌感染的用途 |
| GB0526038D0 (en) | 2005-12-21 | 2006-02-01 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US8323644B2 (en) | 2006-01-17 | 2012-12-04 | Sloan-Kettering Institute For Cancer Research | Therapy-enhancing glucan |
| EP1998802A2 (de) | 2006-03-30 | 2008-12-10 | GlaxoSmithKline Biologicals S.A. | Immunogene zusammensetzung |
| EP2719397A1 (de) | 2006-06-12 | 2014-04-16 | GlaxoSmithKline Biologicals SA | Verwendung von Alpha-Toxin zur Behandlung und Prävention von Staphylococcus-Infektionen |
| EP2208787A1 (de) | 2009-01-19 | 2010-07-21 | Université de Liège | Rekombinantes alpha-Hämolysin-Polypeptid von Staphylococcus aureus, mit einer Deletion in der Stammdomäne und eingefügten heterologen Sequenzen |
| US20100260752A1 (en) | 2009-01-23 | 2010-10-14 | Biosynexus Incorporated | Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria |
| PT3281947T (pt) | 2009-04-03 | 2020-05-07 | Univ Chicago | Composições e métodos relacionados com variantes da proteína a (spa) |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| EP2555794A4 (de) | 2010-04-05 | 2014-01-15 | Univ Chicago | Zusammensetzungen und verfahren im zusammenhang mit protein-a-(spa)-antikörpern als immunreaktionsverstärker |
| CA3088918A1 (en) | 2010-05-05 | 2011-11-10 | New York University | Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| EP2588120B1 (de) | 2010-07-02 | 2017-11-15 | The University of Chicago | Zusammensetzungen und verfahren bezüglich protein-a (spa)-varianten |
| EP2614074A1 (de) | 2010-09-09 | 2013-07-17 | The University of Chicago | Verfahren und zusammensetzungen mit schützenden staphylokokken-antigenen |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| ES2684088T3 (es) | 2011-06-19 | 2018-10-01 | New York University | Métodos de tratamiento y prevención de infecciones por staphylococcus aureus y afecciones asociadas |
| KR20140071318A (ko) | 2011-06-19 | 2014-06-11 | 뉴욕 유니버시티 | 새로운 항-염증제 및 살균제로서의 류코톡신 e/d |
| EP2744517B1 (de) | 2011-08-15 | 2019-03-13 | The University of Chicago | Zusammensetzungen und verfahren in zusammenhang mit antikörpern gegen das staphylokokken-protein a |
| HK1207321A1 (en) | 2012-04-26 | 2016-01-29 | University Of Chicago | Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
| HRP20201127T1 (hr) | 2012-04-26 | 2020-11-27 | University Of Chicago | Antigeni stafilokokne koagulaze i metode primjene istih |
| RU2643331C2 (ru) * | 2012-04-30 | 2018-01-31 | Байотера, Инк. | Способы бета-глюкановой иммунотерапии |
| GB201310008D0 (en) | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
| EP3229833A1 (de) | 2014-12-10 | 2017-10-18 | GlaxoSmithKline Biologicals SA | Behandlungsverfahren |
| US11214600B2 (en) | 2016-02-12 | 2022-01-04 | The University Of Chicago | Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease |
| US11815435B2 (en) | 2017-02-24 | 2023-11-14 | Hibercell, Inc. | Beta glucan immunopharmacodynamics |
| BR112021022902A2 (pt) | 2019-05-14 | 2022-01-25 | Univ Chicago | Métodos e composições que compreendem variantes de proteína a staphylococcus (spa) |
| EP3986555A4 (de) | 2019-06-19 | 2023-06-28 | The Research Foundation for The State University of New York | Verfahren zur behandlung von neointimaler hyperplasie mit f11rl/jam-a-inhibitoren |
| WO2021051136A1 (en) | 2019-09-13 | 2021-03-18 | The University Of Chicago | Methods and compositions for treating staphylococcal infections |
| IL291821A (en) | 2019-10-02 | 2022-06-01 | Janssen Vaccines & Prevention Bv | Staphylococcus peptides and methods of use |
| US20250228908A1 (en) | 2022-04-01 | 2025-07-17 | Icahn School Of Medicine At Mount Sinai | Treating orthopedic injury with a vector driving expression of acid ceramidase |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4739046A (en) * | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
| US4900722A (en) * | 1985-08-19 | 1990-02-13 | Bioglucans, L.P. | Methods and compositions for prophylactic and therapeutic treatment of infections |
| US5032401A (en) * | 1989-06-15 | 1991-07-16 | Alpha Beta Technology | Glucan drug delivery system and adjuvant |
| CA2040374C (en) * | 1990-07-06 | 1998-06-16 | Gunnar Rorstad | Process for enhancing the resistance of aquatic animals to disease |
| AU681573B2 (en) * | 1991-11-22 | 1997-09-04 | Glaxosmithkline Biologicals Sa | Type I and type II surface antigens associated with (staphylococcus epidermidis) |
| WO1996014873A2 (en) | 1994-11-16 | 1996-05-23 | Sri International | COVALENTLY BOUND β-GLUCAN CONJUGATES IN TARGETED DELIVERY |
| US5785975A (en) * | 1995-06-26 | 1998-07-28 | Research Triangle Pharmaceuticals | Adjuvant compositions and vaccine formulations comprising same |
| US5770208A (en) * | 1996-09-11 | 1998-06-23 | Nabi | Staphylococcus aureus B-linked hexosamine antigen |
-
1999
- 1999-09-14 CA CA002344166A patent/CA2344166C/en not_active Expired - Fee Related
- 1999-09-14 PT PT99969030T patent/PT1121135E/pt unknown
- 1999-09-14 AU AU60332/99A patent/AU6033299A/en not_active Abandoned
- 1999-09-14 DK DK99969030T patent/DK1121135T3/da active
- 1999-09-14 AT AT99969030T patent/ATE421883T1/de active
- 1999-09-14 EP EP99969030A patent/EP1121135B1/de not_active Expired - Lifetime
- 1999-09-14 WO PCT/US1999/020787 patent/WO2000015238A1/en not_active Ceased
- 1999-09-14 DE DE69940371T patent/DE69940371D1/de not_active Expired - Lifetime
- 1999-09-14 US US09/395,360 patent/US6355625B1/en not_active Expired - Lifetime
- 1999-09-14 ES ES99969030T patent/ES2321892T3/es not_active Expired - Lifetime
-
2009
- 2009-01-29 CY CY20091100108T patent/CY1109437T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000015238A9 (en) | 2000-10-12 |
| CY1109437T1 (el) | 2014-08-13 |
| AU6033299A (en) | 2000-04-03 |
| ES2321892T3 (es) | 2009-06-12 |
| EP1121135B1 (de) | 2009-01-28 |
| CA2344166A1 (en) | 2000-03-23 |
| US6355625B1 (en) | 2002-03-12 |
| EP1121135A4 (de) | 2005-03-16 |
| EP1121135A1 (de) | 2001-08-08 |
| WO2000015238A1 (en) | 2000-03-23 |
| WO2000015238B1 (en) | 2000-08-31 |
| DK1121135T3 (da) | 2009-03-23 |
| DE69940371D1 (de) | 2009-03-19 |
| PT1121135E (pt) | 2009-03-05 |
| CA2344166C (en) | 2008-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE421883T1 (de) | Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline | |
| BR9917152A (pt) | Composição para tratamento terapêutico ou profilático de infecção estreptocócica e método e uso respectivos | |
| FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
| TR200000059T2 (tr) | Piridin türevleri | |
| TR199900856T2 (xx) | Bron�la ilgili terapi maddeleri olarak benzonaftiridinler | |
| NO965378L (no) | Pyrazolo- og pyrrolopyridiner | |
| ID21526A (id) | 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus | |
| DE69928952D1 (de) | Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe | |
| DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
| ES2191208T3 (es) | Oxiimino-pregnano-carbolactonas. | |
| DE60043868D1 (de) | Abgeschwächte Mikroorganismen für die Behandlung von Infektionen | |
| DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
| ES2009140A6 (es) | Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. | |
| DE69631381D1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
| ATE199321T1 (de) | Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen. | |
| DK1042492T3 (da) | Humaniserede monoklonale antistoffer der beskytter med Shiga-toksininducerede sygdomme | |
| EA200100700A1 (ru) | Гены и белки и их применение | |
| BRPI0413684A (pt) | compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos | |
| ATE317263T1 (de) | Diphosphonat derivate von therapeutisch wirksamen stoffen | |
| DE69931784D1 (de) | Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung | |
| EA200200704A1 (ru) | Ослабленные микроорганизмы для лечения инфекции | |
| BR0308734A (pt) | Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção | |
| ATE108832T1 (de) | Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin. | |
| IT1276454B1 (it) | Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico. | |
| NO982151D0 (no) | Hemoregulatoriske forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1121135 Country of ref document: EP |